Participants needed for RSV clinical trial

Area residents are being asked to participate in a clinical trial for a new vaccine for respiratory syncytial virus or RSV.

Javara, which focuses on delivering access to clinical trials, is partnering with Privia Health Group to recruit participants for a study in Georgia, Maryland and Texas for an RSV vaccine. RSV is a frequent cause of severe acute respiratory illness in older adults.